- ►endojournals.org O Sabri, M Zimny, G Schulz, M … - Journal of Clinical …, 1999 - Endocrine Soc There is controversy whether simultaneous thyrostatic medication influences the outcome of
radioiodine ( 131 I) therapy in Graves' disease by reducing the absorbed energy dose of 131 I when
delivering a standard dose. We ... Cited by 99 - Related articles - BL Direct - All 4 versions
RM Tuttle, T Patience, S Budd - Thyroid, 1995 - liebertonline.com Page 1. THYROID Volume 5, Number 4, 1995 Mary Ann Liebert, Inc. Treatment with Propylthiouracil before
Radioactive Iodine Therapy Is Associated with a Higher Treatment Failure Rate Than Therapy with Radioactive
Iodine Alone in Graves' Disease R. MICHAEL TUTTLE,1 TROY PATIENCE,2 and STEVEN BUDD3 ... Cited by 86 - Related articles - BL Direct - All 3 versions
- ►endojournals.org VA Andrade, JL Gross, AL Maia - Journal of Clinical Endocrinology & …, 2001 - Endocrine Soc The effect of antithyroid drugs on the efficacy of radioiodine ( 131 I) treatment is still
controversial. This study evaluated the effect of methimazole pretreatment on the efficacy of 131 I
therapy in Graves' hyperthyroidism. ... Cited by 81 - Related articles - BL Direct - All 6 versions
LD Hancock, RM Tuttle, H LeMar, J Bauman, … - Clinical …, 1997 - ingentaconnect.com Propylthiouracil discontinued 4-7 days before radioiodine dosing is associated with a significant
increase in the failure rate of a single dose of radioiodine. Discontinuation of the
propylthiouracil for at least a ... Cited by 74 - Related articles - BL Direct - All 4 versions
MM Kaplan, DA Meier, HJ Dworkin - … and metabolism clinics of North America, 1998 - Elsevier Radioactive iodine (RAI) therapy for hyperthyroidism was first used in 1941 by physicians at
Massachusetts General Hospital in Boston. 7 and 58 The first nuclide used was 130 I, which has a
half-life of 12.4 hours. In 1946, ... Cited by 58 - Related articles - BL Direct - All 11 versions
- ►endojournals.org DS Cooper - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc Antithyroid drugs have been in use for over half a century, and much is now known about their
mechanism of action, pharmacokinetics, and clinical pharmacology (1). Somewhat surprisingly perhaps,
clinicians are still challenged on ... Cited by 54 - Related articles - All 4 versions
- ►endojournals.org VA Andrade, JL Gross, AL Maia - Journal of Clinical Endocrinology & …, 1999 - Endocrine Soc Radioiodine ( 131 I) is the preferred definitive treatment for Graves' hyperthyroidism. Pretreatment
with antithyroid drugs is often used to avoid thyroid hormone discharge after 131 I ablation.
However, this may represent an ... Cited by 48 - Related articles - BL Direct - All 4 versions
- ►endojournals.org HB Burch, BL Solomon, DS Cooper, P … - Journal of Clinical …, 2001 - Endocrine Soc Acute changes in thyroid hormone levels before and after radioiodine therapy for Graves' disease
were compared in 42 patients randomized to receive either antithyroid drug pretreatment or no
pretreatment. Five patients ... Cited by 42 - Related articles - BL Direct - All 6 versions
